X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2018 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare ALEMBIC LTD with SUVEN LIFE - Equitymaster
  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

ALEMBIC LTD vs SUVEN LIFE - Comparison Results

ALEMBIC LTD    Change

Alembic Limited, in its 99 years of existence, has evolved from being a tincture manufacturer to one of the prominent indigenous pharma companies in India. It is among the top players in the macrolides (anti-infective) and anti-microbials (animal hea... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    ALEMBIC LTD SUVEN LIFE ALEMBIC LTD/
SUVEN LIFE
 
P/E (TTM) x 121.8 19.3 631.0% View Chart
P/BV x 4.5 3.6 126.3% View Chart
Dividend Yield % 0.2 1.0 23.7%  

Financials

 ALEMBIC LTD   SUVEN LIFE
EQUITY SHARE DATA
    ALEMBIC LTD
Mar-16
SUVEN LIFE
Mar-16
ALEMBIC LTD/
SUVEN LIFE
5-Yr Chart
Click to enlarge
High Rs53339 15.6%   
Low Rs29144 20.3%   
Sales per share (Unadj.) Rs4.739.2 12.0%  
Earnings per share (Unadj.) Rs8.87.5 117.6%  
Cash flow per share (Unadj.) Rs9.08.8 102.6%  
Dividends per share (Unadj.) Rs0.152.00 7.5%  
Dividend yield (eoy) %0.40.8 44.1%  
Book value per share (Unadj.) Rs27.749.0 56.6%  
Shares outstanding (eoy) m267.03127.28 209.8%   
Bonus/Rights/Conversions ---  
Price / Sales ratio x8.76.2 141.4%   
Avg P/E ratio x4.732.4 14.5%  
P/CF ratio (eoy) x4.627.5 16.6%  
Price / Book Value ratio x1.54.9 30.0%  
Dividend payout %1.726.8 6.4%   
Avg Mkt Cap Rs m10,96230,732 35.7%   
No. of employees `000NA1.0 0.0%   
Total wages/salary Rs m238416 57.2%   
Avg. sales/employee Rs ThNM5,236.1-  
Avg. wages/employee Rs ThNM436.5-  
Avg. net profit/employee Rs ThNM995.5-  
INCOME DATA
Net Sales Rs m1,2604,995 25.2%  
Other income Rs m264194 136.3%   
Total revenues Rs m1,5245,189 29.4%   
Gross profit Rs m831,233 6.7%  
Depreciation Rs m61167 36.7%   
Interest Rs m054 0.6%   
Profit before tax Rs m2851,205 23.6%   
Minority Interest Rs m00-   
Prior Period Items Rs m2,0960-   
Extraordinary Inc (Exp) Rs m-320-   
Tax Rs m6255 2.4%   
Profit after tax Rs m2,343950 246.7%  
Gross profit margin %6.624.7 26.6%  
Effective tax rate %2.121.2 10.1%   
Net profit margin %185.919.0 977.7%  
BALANCE SHEET DATA
Current assets Rs m1,6894,986 33.9%   
Current liabilities Rs m4861,042 46.7%   
Net working cap to sales %95.479.0 120.9%  
Current ratio x3.54.8 72.6%  
Inventory Days Days21761 355.7%  
Debtors Days Days8139 207.1%  
Net fixed assets Rs m1,6243,126 52.0%   
Share capital Rs m534127 419.6%   
"Free" reserves Rs m5,9603,717 160.3%   
Net worth Rs m7,4046,236 118.7%   
Long term debt Rs m104432 24.1%   
Total assets Rs m8,0108,079 99.1%  
Interest coverage x950.723.2 4,092.9%   
Debt to equity ratio x00.1 20.3%  
Sales to assets ratio x0.20.6 25.4%   
Return on assets %29.312.4 235.4%  
Return on equity %31.615.2 207.8%  
Return on capital %31.318.9 165.7%  
Exports to sales %2.987.5 3.4%   
Imports to sales %28.912.2 236.0%   
Exports (fob) Rs m374,371 0.8%   
Imports (cif) Rs m364611 59.5%   
Fx inflow Rs m374,666 0.8%   
Fx outflow Rs m365942 38.7%   
Net fx Rs m-3283,724 -8.8%   
CASH FLOW
From Operations Rs m346922 37.5%  
From Investments Rs m-48-619 7.7%  
From Financial Activity Rs m-301-698 43.1%  
Net Cashflow Rs m-3-396 0.8%  

Share Holding

Indian Promoters % 64.0 63.4 100.9%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 0.2 0.0 -  
FIIs % 9.7 0.0 -  
ADR/GDR % 0.0 0.0 -  
Free float % 26.1 36.5 71.5%  
Shareholders   54,701 37,287 146.7%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare ALEMBIC LTD With:   WOCKHARDT LTD.  J.B.CHEMICALS  DR. REDDYS LAB  DIVIS LABORATORIES  FULFORD INDIA  

Compare ALEMBIC LTD With:   ACTAVIS (US)  MYLAN (US)  ADCOCK INGRAM (S. Africa)  TEVA PHARMA (Israel)  



Today's Market

Of PNB Fraud, Rising Troubles at PSBs, and Top Cues in Focus Today(Pre-Open)

Share markets in India closed on a negative note yesterday. At the closing bell yesterday, the BSE Sensex stood lower by 236 points and the NSE Nifty closed down by 74 points.

Related Views on News

Suven Lifesciences: Profits Decline due to Higher tax outgo in the quarter (Quarterly Results Update - Detailed)

Sep 22, 2017

Muted growth in CRAMS segment continues to impact topline.

Aster DM Healthcare (IPO)

Feb 10, 2018

Should you subscribe to the IPO of Aster DM Healthcare Ltd?

Dr Reddy's: Milestone Payment Drives Sales (Quarterly Results Update - Detailed)

Feb 9, 2018

US business was hit by pricing pressure although there was growth sequentially led by new product launches.

Lupin: US market Declines Due to Higher Base Effect of FY17 (Quarterly Results Update - Detailed)

Feb 9, 2018

Price erosion in generic US drugs continues but seems to be bottoming out.

Biocon: US Pricing Pressure Takes Toll (Quarterly Results Update - Detailed)

Feb 2, 2018

Pricing pressure in the US and costs of the Malaysian facility hit Biocon's profits in the third quarter.

More Views on News

Most Popular

Follow India's Super Investors to Make Big Money in the Market Crash(The 5 Minute Wrapup)

Feb 8, 2018

Has the sell-off in the markets left India's super investors unduly worried?

The Era of Easy Money is Coming to an End. What Happens Now?(Vivek Kaul's Diary)

Feb 9, 2018

The easy money policy of the Federal Reserve of the United States, which drove up stock markets all over the world, is ending, with the Federal Reserve looking to shrink its balance sheet.

The Markets Want Your Money. Don't Give It to Them.(Smart Contrarian)

Feb 9, 2018

MFs are having a gala time taking money from over-eager investors and funneling it into equities. Smart investors, though, know better than to do that.

The Big Gamble(The Honest Truth)

Feb 15, 2018

Once you accept the fact that elections are round the corner and that this budget is geared to reach a 40% target, everything makes sense.

Rising Dominance of Mutual Funds(Chart Of The Day)

Feb 8, 2018

Domestic money flow into Indian equities surpassed foreign fund flows in the recent years. But will it continue in volatile market?

More

Small Investments
BIG Returns

Zero To Millions Guide 2018
Get our special report, Zero To Millions
(2018 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

ALEMBIC LTD SHARE PRICE


Feb 19, 2018 (Close)

TRACK ALEMBIC LTD

  • Track your investment in ALEMBIC LTD with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

ALEMBIC LTD 8-QTR ANALYSIS

COMPARE ALEMBIC LTD WITH

MARKET STATS